Revalia Bio, a New Haven, Connecticut-based biotech company revolutionizing drug development with human data trials, raised $14.5 million in a seed fundraising round led by America’s Frontier Fund with participation from Sierra Ventures, Roger Ferguson, and others.
More on Crunchbase News →

